Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Ronald J. Maggiore"'
Autor:
Amy R. MacKenzie, Enrique Soto-Perez-de-Celis, Ronald J. Maggiore, Janette K. Merrill, Grant R. Williams, Kimberly T Smith, William Dale, Heidi D. Klepin, Sweatha Katta
Publikováno v:
JCO Oncol Pract
PURPOSE: For patients with cancer who are older than 65 years, the 2018 ASCO Guideline recommends geriatric assessment (GA) be performed. However, there are limited data on providers’ practices using GA. Therefore, ASCO’s Geriatric Oncology Task
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1197413168445a28cc2b2bc7fbbe5d77
https://doi.org/10.1200/op.20.00442
https://doi.org/10.1200/op.20.00442
Autor:
Marie Flannery, Richard F. Dunne, Nikesha Gilmore, Sindhuja Kadambi, Kah Poh Loh, Julia E Inglis, Allison Magnuson, Supriya G. Mohile, Erika Ramsdale, Ronald J. Maggiore, Mostafa R. Mohamed, Jason Zittel
Publikováno v:
Nat Rev Clin Oncol
Despite substantial improvements in the outcomes of patients with cancer over the past two decades, older adults (aged ≥65 years) with cancer are a rapidly increasing population and continue to have worse outcomes than their younger counterparts. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0798d38842887552953d1b169f8038
https://doi.org/10.1038/s41571-020-0421-z
https://doi.org/10.1038/s41571-020-0421-z
Autor:
Tanya M. Wildes, Enrique Soto-Perez-de-Celis, Ronald J. Maggiore, Beatriz Korc-Grodzicki, Ravindran Kanesvaran, Tina Hsu, Peggy S. Burhenn
Publikováno v:
J Geriatr Oncol
The majority of patients with cancer are over the age of 65. This patient population often has unique care needs. Thus, clinicians require additional competencies and skills to care for this population. Most clinicians, however, receive little to no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8403bd21c959c376dc200abaaa6852e
https://doi.org/10.1016/j.jgo.2019.10.020
https://doi.org/10.1016/j.jgo.2019.10.020
Publikováno v:
Journal of Geriatric Oncology. 11:496-502
The purpose of this study was to explore the associations between age and frailty with immune-related adverse events (irAEs) among patients with cutaneous malignancies receiving immune checkpoint inhibitor (ICI) therapy.A retrospective review of all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b56e91d7392574d77af17c69b32dac0e
https://doi.org/10.1016/j.jgo.2019.07.005
https://doi.org/10.1016/j.jgo.2019.07.005
Autor:
Susan Messing, Kah Poh Loh, Emily Szuba, Karim Welaya, Ronald J. Maggiore, Allison Magnuson, Supriya G. Mohile
Publikováno v:
J Geriatr Oncol
Objectives Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, but outcomes in older adults are not well defined. We evaluated the associations of geriatric assessment (GA) domains with treatment-related outcomes in older
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c5d2646a948259b340549c788734307
https://doi.org/10.1016/j.jgo.2019.05.021
https://doi.org/10.1016/j.jgo.2019.05.021
Autor:
Jennifer Novak, Annette Goldberg, Kavita Dharmarajan, Arya Amini, Ronald J. Maggiore, Carolyn J. Presley, Ginah Nightingale
Publikováno v:
J Geriatr Oncol
Polypharmacy is characterized by the simultaneous use of multiple medications, including prescription drugs, over-the-counter drugs, and nutritional supplements. Polypharmacy is known to increase the risk of adverse drugs reactions, drug-drug interac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13f1be7ee1000e858701e3d930c12c26
https://europepmc.org/articles/PMC9283217/
https://europepmc.org/articles/PMC9283217/
Autor:
Brian A. Van Tine, Noha N. Salama, Conor E. Steuer, Juneko E. Grilley-Olson, Nabil F. Saba, Assuntina G. Sacco, Jessica Ley, Ronald J. Maggiore, Kevin Palka, Peter Oppelt, Francis P. Worden, Kathryn Trinkaus, Prakash Neupane, Douglas Adkins
Publikováno v:
The Lancet Oncology. 20:1295-1305
Summary Background Most head and neck squamous-cell carcinomas (HNSCCs) are driven by p16INK4A inactivation and cyclin D1 overexpression that results in hyperactivation of cyclin-dependent kinase 4 and 6 (CDK4/6), rather than by the human papillomavi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d6e395a864abf4f528ebfc3a7fb530e
https://doi.org/10.1016/s1470-2045(19)30405-x
https://doi.org/10.1016/s1470-2045(19)30405-x
Publikováno v:
Journal of Geriatric Oncology. 10:384-388
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43495c295761b6ed5d2fd4690d8e2a64
https://doi.org/10.1016/j.jgo.2019.01.023
https://doi.org/10.1016/j.jgo.2019.01.023
Immune Checkpoint Inhibitors in Real‐World Treatment of Older Adults with Non–Small Cell Lung Cancer
Autor:
Kah Poh Loh, Eugene Muchnik, Vered Estrah, Myla Strawderman, Allison Magnuson, Ronald J. Maggiore, Supriya G. Mohile
Publikováno v:
J Am Geriatr Soc
OBJECTIVE To evaluate the efficacy and toxicity of immune checkpoint inhibitors (ICIs) in older patients with advanced non-small cell lung cancer (NSCLC) seen in routine clinical practice. DESIGN Retrospective study. SETTING Single academic instituti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85fb2331d31f376950082b65e7a4027d
https://doi.org/10.1111/jgs.15750
https://doi.org/10.1111/jgs.15750
Autor:
Jess Hatfield, Timur Mitin, Ronald J. Maggiore, Shearwood McClelland, Yiyi Chen, Catherine Degnin, Jia Luo
Publikováno v:
Clinical Breast Cancer. 18:498-503
Introduction Primary breast angiosarcoma is a rare malignancy with no clinical trials to guide management. The current use of surgery, chemotherapy, and radiotherapy among North American oncologists is unknown. Patients and Methods An institutional r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47b2893d8324acbbe16cdb9df65d4089
https://doi.org/10.1016/j.clbc.2018.09.009
https://doi.org/10.1016/j.clbc.2018.09.009